A Fujifilm contribui para um mundo melhor, mais saudável e mais interessante.
Proprietary technology for early diagnosis
Fujifilm was the first to receive U.S. Food and Drug Administration
(FDA) PMA approval for computed radiography in mammography. With over
6,000 units installed, the FCR PROFECT CS/ONE has earned the acclaim and
trust of healthcare institutions worldwide. The launch of the AMULET DR
mammography system, featuring new direct-conversion FPD, further
underlines Fujifilm's commitment to providing the best solutions to
support women's health.
High-resolution single plate FCR reader capable of 50µm resolution for mammography featuring dual-side reading.
FCR CAPSULA XLII equipped with the optional capability of 50-micron reading with the HR-V can visualize more fine and minute structures. It is suited for mammography applications.
Computer aided detection (CAD) system analyses images to help detect breast abnormalities.
A dedicated quality control program for Fujifilm digital mammography systems to support stable image quality in screening and diagnosis.
Fujifilm Corporation is a wholly-owned subsidiary of Fujifilm Holdings Corporation.